These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3847 related items for PubMed ID: 16425290

  • 1. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A.
    J Surg Oncol; 2006 Feb 01; 93(2):109-19. PubMed ID: 16425290
    [Abstract] [Full Text] [Related]

  • 2. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.
    J Surg Oncol; 2003 Oct 01; 84(2):63-7. PubMed ID: 14502778
    [Abstract] [Full Text] [Related]

  • 3. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL, GIVOM.
    Eur J Surg Oncol; 2008 May 01; 34(5):508-13. PubMed ID: 17614245
    [Abstract] [Full Text] [Related]

  • 4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A.
    Chir Ital; 2007 May 01; 59(5):693-9. PubMed ID: 18019642
    [Abstract] [Full Text] [Related]

  • 5. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU.
    Eur J Surg Oncol; 2006 Mar 01; 32(2):148-52. PubMed ID: 16387467
    [Abstract] [Full Text] [Related]

  • 6. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE.
    Ann Surg Oncol; 2008 Jul 01; 15(7):1996-2005. PubMed ID: 18415650
    [Abstract] [Full Text] [Related]

  • 7. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB.
    J Surg Oncol; 2006 Feb 01; 93(2):129-32. PubMed ID: 16425295
    [Abstract] [Full Text] [Related]

  • 8. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM.
    Eur J Surg Oncol; 2007 Sep 01; 33(7):832-7. PubMed ID: 17197151
    [Abstract] [Full Text] [Related]

  • 9. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ.
    Ann Surg Oncol; 2004 Nov 01; 11(11):1018-24. PubMed ID: 15525832
    [Abstract] [Full Text] [Related]

  • 10. Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH, Fey JV, Borgen PI, Van Zee KJ.
    Oncol Nurs Forum; 2004 Jul 01; 31(4):691-8. PubMed ID: 15252425
    [Abstract] [Full Text] [Related]

  • 11. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.
    J Clin Oncol; 2009 Jun 20; 27(18):2946-53. PubMed ID: 19364968
    [Abstract] [Full Text] [Related]

  • 12. Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ.
    Ann Surg Oncol; 2007 May 20; 14(5):1653-61. PubMed ID: 17295084
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of sentinel lymph node biopsy in male breast cancer.
    Cimmino VM, Degnim AC, Sabel MS, Diehl KM, Newman LA, Chang AE.
    J Surg Oncol; 2004 May 01; 86(2):74-7. PubMed ID: 15112248
    [Abstract] [Full Text] [Related]

  • 14. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S, Sanidas E, Askoxilakis J, Stathaki M, Charalambakis V, Daboudi M, Voutoufianaki I, Kafousi M, Stathopoulos E, Tsiftsis D, Karkavitsas N.
    Nucl Med Commun; 2009 Jan 01; 30(1):48-53. PubMed ID: 19020472
    [Abstract] [Full Text] [Related]

  • 15. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Christiansen P.
    Breast; 2008 Apr 01; 17(2):138-47. PubMed ID: 17928226
    [Abstract] [Full Text] [Related]

  • 16. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A, Newcombe RG, Chhabra A, Mansel RE.
    Ann Surg Oncol; 2008 Jan 01; 15(1):262-7. PubMed ID: 17879117
    [Abstract] [Full Text] [Related]

  • 17. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK, Dauphine CE, Vargas MP, Gonzalez K, Burla M, Kaufmann P, Vargas HI.
    Am Surg; 2006 Oct 01; 72(10):939-42. PubMed ID: 17058740
    [Abstract] [Full Text] [Related]

  • 18. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP.
    Cancer; 2010 Mar 01; 116(5):1243-51. PubMed ID: 20087958
    [Abstract] [Full Text] [Related]

  • 19. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ.
    Cancer; 2003 Aug 15; 98(4):690-6. PubMed ID: 12910511
    [Abstract] [Full Text] [Related]

  • 20. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G, Kühn T, Moser L, Remmel E, Kreienberg R.
    Eur J Surg Oncol; 2009 Jul 15; 35(7):696-701. PubMed ID: 18838245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 193.